Black Diamond Therapeutics (BDTX) News Today $2.87 +0.13 (+4.74%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.87 0.00 (0.00%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BDTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Rating of "Buy" from AnalystsJuly 11 at 2:11 AM | marketbeat.comRaymond James Financial Upgrades Black Diamond Therapeutics (NASDAQ:BDTX) to OutperformJuly 3, 2025 | americanbankingnews.comBlack Diamond Therapeutics (NASDAQ:BDTX) Coverage Initiated at Raymond James FinancialJuly 1, 2025 | marketbeat.comBlack Diamond Therapeutics Inc. BDTX (U.S.: Nasdaq) - The Wall Street JournalJune 25, 2025 | wsj.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Rating of "Buy" from AnalystsJune 16, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street ZenJune 14, 2025 | marketbeat.comBlack Diamond Therapeutics: Targeted Approach And Early Efficacy Signals Create Potential For Significant UpsideJune 10, 2025 | seekingalpha.comBlack Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Lowered by Wall Street ZenJune 6, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLCJune 5, 2025 | marketbeat.comShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Declines By 14.4%June 4, 2025 | marketbeat.comBlack Diamond Therapeutics to Participate in Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Recommendation of "Buy" from BrokeragesMay 24, 2025 | marketbeat.comBlack Diamond Therapeutics (NASDAQ:BDTX) Rating Increased to Buy at StockNews.comMay 24, 2025 | marketbeat.comVestal Point Capital LP Raises Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 21, 2025 | marketbeat.comPrice T Rowe Associates Inc. MD Cuts Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 21, 2025 | marketbeat.comTang Capital Management LLC Purchases 700,000 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 20, 2025 | marketbeat.comDimensional Fund Advisors LP Has $1.42 Million Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 18, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLCMay 17, 2025 | marketbeat.comTD Cowen Remains a Buy on Black Diamond Therapeutics (BDTX)May 15, 2025 | theglobeandmail.comBlack Diamond Therapeutics, Inc: Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 13, 2025 | finanznachrichten.deBlack Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 12, 2025 | globenewswire.comPositive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past yearMay 4, 2025 | finance.yahoo.comBoxer Capital Management LLC Acquires New Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)May 4, 2025 | marketbeat.comBlack Diamond Therapeutics (BDTX) to Release Quarterly Earnings on ThursdayMay 3, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Sells 267,668 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)April 29, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Bought by Renaissance Technologies LLCApril 28, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Short Interest Up 42.0% in MarchApril 20, 2025 | marketbeat.comAffinity Asset Advisors LLC Purchases Shares of 559,163 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)April 17, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Position Reduced by Kennedy Capital Management LLCApril 17, 2025 | marketbeat.comBlack Diamond Therapeutics to Participate in Upcoming Investor ConferencesMarch 31, 2025 | globenewswire.comBlack Diamond Therapeutics Trades Well Below Cash After Lucrative Deal With ServierMarch 25, 2025 | seekingalpha.comWhat is Wedbush's Estimate for BDTX Q1 Earnings?March 24, 2025 | marketbeat.comGrowth N. V. Biotech Sells 5,784,292 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) StockMarch 21, 2025 | marketbeat.comStifel Nicolaus Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)March 21, 2025 | markets.businessinsider.comWhat is HC Wainwright's Estimate for BDTX Q1 Earnings?March 21, 2025 | marketbeat.comBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Major Shareholder Sells $11,973,484.44 in StockMarch 21, 2025 | insidertrades.comPenny Stocks To Follow Now - March 19thMarch 20, 2025 | marketbeat.comServier and Black Diamond sign deal for solid tumours therapyMarch 20, 2025 | finance.yahoo.comBlack Diamond Therapeutics (NASDAQ:BDTX) Given Outperform Rating at WedbushMarch 20, 2025 | marketbeat.comBlack Diamond Therapeutics Sees Unusually High Options Volume (NASDAQ:BDTX)March 20, 2025 | marketbeat.comBlack Diamond, Servier announce global licensing agreement for BDTX-4933March 19, 2025 | markets.businessinsider.comBlack Diamond stock soars on licensing dealMarch 19, 2025 | in.investing.comBlack Diamond Therapeutics Shares Surge on Servier Licensing DealMarch 19, 2025 | marketwatch.comThis Biotech Is Finding Mid-Week Success Following Licensing Agreement AnnouncementMarch 19, 2025 | msn.comBlack Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 MillionMarch 19, 2025 | benzinga.comBlack Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-HighMarch 19, 2025 | msn.comBlack Diamond Therapeutics (NASDAQ:BDTX) Price Target Raised to $12.00March 19, 2025 | marketbeat.comServier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology TherapyMarch 19, 2025 | tmcnet.comServier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology TherapyMarch 19, 2025 | globenewswire.comBlack Diamond price target raised to $12 from $11 at H.C. WainwrightMarch 18, 2025 | markets.businessinsider.com Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BDTX Media Mentions By Week BDTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDTX News Sentiment▼1.800.99▲Average Medical News Sentiment BDTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDTX Articles This Week▼22▲BDTX Articles Average Week Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARVN News Today IOVA News Today TBPH News Today XNCR News Today ATAI News Today KROS News Today MNMD News Today ORGO News Today TYRA News Today MAZE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BDTX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDTX Stock Alerts